Published in Am J Reprod Immunol on May 01, 2008
Hidden talents of natural killers: NK cells in innate and adaptive immunity. EMBO Rep (2009) 1.60
Vascular endothelial growth factor C facilitates immune tolerance and endovascular activity of human uterine NK cells at the maternal-fetal interface. J Immunol (2009) 1.32
How might infant and paediatric immune responses influence malaria vaccine efficacy? Parasite Immunol (2009) 1.11
Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodies. MAbs (2010) 1.06
Toxicological pathology in the rat placenta. J Toxicol Pathol (2011) 1.03
MicroRNAs, immune cells and pregnancy. Cell Mol Immunol (2014) 0.97
MicroRNA regulation of natural killer cells. Front Immunol (2013) 0.94
Innate immunity, coagulation and placenta-related adverse pregnancy outcomes. Thromb Res (2009) 0.92
Maternal floor infarction/massive perivillous fibrin deposition: a manifestation of maternal antifetal rejection? Am J Reprod Immunol (2013) 0.86
Maternal HLA panel-reactive antibodies in early gestation positively correlate with chronic chorioamnionitis: evidence in support of the chronic nature of maternal anti-fetal rejection. Am J Reprod Immunol (2011) 0.86
Natural killer cells and regulatory T cells in early pregnancy loss. Int J Dev Biol (2014) 0.86
Immune surveillance of the maternal/fetal interface: controversies and implications. Trends Endocrinol Metab (2010) 0.85
Insights into the paracrine effects of uterine natural killer cells. Mol Med Rep (2014) 0.77
Acute Fetal Demise with First Trimester Maternal Infection Resulting from Listeria monocytogenes in a Nonhuman Primate Model. MBio (2017) 0.75
Role of HLA-G and NCR in protection of umbilical cord blood haematopoietic stem cells from NK cell mediated cytotoxicity. J Cell Mol Med (2011) 0.75
Immunopharmacology of ulipristal as an emergency contraceptive. Int J Womens Health (2011) 0.75
Innate or adaptive immunity? The example of natural killer cells. Science (2011) 8.68
Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature (2005) 7.40
Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci U S A (2002) 5.17
TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity (2004) 4.50
In vivo developmental stages in murine natural killer cell maturation. Nat Immunol (2002) 4.25
Cytokine-induced memory-like natural killer cells. Proc Natl Acad Sci U S A (2009) 3.74
Functional interactions between dendritic cells and NK cells during viral infection. Nat Immunol (2002) 3.20
NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation. Nat Immunol (2002) 2.92
Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. J Clin Invest (2003) 2.79
Natural killer cells and viral infections. Curr Opin Immunol (2003) 2.63
Minimal differentiation of classical monocytes as they survey steady-state tissues and transport antigen to lymph nodes. Immunity (2013) 2.61
Gain of virulence caused by loss of a gene in murine cytomegalovirus. J Virol (2004) 2.43
HLA alleles determine differences in human natural killer cell responsiveness and potency. Proc Natl Acad Sci U S A (2008) 2.31
Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D. J Immunol (2002) 2.26
Liver-resident NK cells confer adaptive immunity in skin-contact inflammation. J Clin Invest (2013) 2.21
NKG2D function protects the host from tumor initiation. J Exp Med (2005) 2.19
Escape of mutant double-stranded DNA virus from innate immune control. Immunity (2004) 2.14
Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands. J Immunol (2007) 2.12
Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors. Nat Immunol (2003) 2.09
Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells. Elife (2014) 1.97
MHC class I-deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I-sufficient environment. J Exp Med (2010) 1.95
Continuous engagement of a self-specific activation receptor induces NK cell tolerance. J Exp Med (2008) 1.86
Unifying concepts of MHC-dependent natural killer cell education. Trends Immunol (2011) 1.85
Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo. J Immunol (2005) 1.85
Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells. Proc Natl Acad Sci U S A (2003) 1.85
Induction of natural killer cell responses by ectromelia virus controls infection. J Virol (2007) 1.62
2'-O methylation of the viral mRNA cap by West Nile virus evades ifit1-dependent and -independent mechanisms of host restriction in vivo. PLoS Pathog (2012) 1.62
Hidden talents of natural killers: NK cells in innate and adaptive immunity. EMBO Rep (2009) 1.60
Natural killer cell tolerance licensing and other mechanisms. Adv Immunol (2009) 1.60
Natural killer cells utilize both perforin and gamma interferon to regulate murine cytomegalovirus infection in the spleen and liver. J Virol (2005) 1.55
Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors. J Immunol (2005) 1.53
Structural mechanism of ER retrieval of MHC class I by cowpox. PLoS Biol (2012) 1.49
Two mechanistically distinct immune evasion proteins of cowpox virus combine to avoid antiviral CD8 T cells. Cell Host Microbe (2009) 1.48
Ly49E-dependent inhibition of natural killer cells by urokinase plasminogen activator. Blood (2008) 1.45
Role of natural killer cells in innate protection against lethal ebola virus infection. J Exp Med (2004) 1.44
MHC Class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature 358: 66-70, 1992. J Immunol (2006) 1.43
Costimulation through NKG2D enhances murine CD8+ CTL function: similarities and differences between NKG2D and CD28 costimulation. J Immunol (2005) 1.42
Murine cytomegalovirus displays selective infection of cells within hours after systemic administration. J Gen Virol (2009) 1.40
NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer. J Exp Med (2004) 1.35
Zoonotic orthopoxviruses encode a high-affinity antagonist of NKG2D. J Exp Med (2007) 1.34
Multiple ITAM-coupled NK-cell receptors engage the Bcl10/Malt1 complex via Carma1 for NF-kappaB and MAPK activation to selectively control cytokine production. Blood (2008) 1.34
IFN-dependent down-regulation of the NKG2D ligand H60 on tumors. J Immunol (2006) 1.31
Altered NK cell development and enhanced NK cell-mediated resistance to mouse cytomegalovirus in NKG2D-deficient mice. Immunity (2009) 1.29
Cowpox virus exploits the endoplasmic reticulum retention pathway to inhibit MHC class I transport to the cell surface. Cell Host Microbe (2007) 1.27
Costimulation of multiple NK cell activation receptors by NKG2D. J Immunol (2002) 1.27
A temporal role of type I interferon signaling in CD8+ T cell maturation during acute West Nile virus infection. PLoS Pathog (2011) 1.26
DAP12 signaling directly augments proproliferative cytokine stimulation of NK cells during viral infections. J Immunol (2006) 1.26
Effects of MHC class I alleles on licensing of Ly49A+ NK cells. J Immunol (2010) 1.24
Coordinate expression of cytokines and chemokines by NK cells during murine cytomegalovirus infection. J Immunol (2004) 1.19
Natural killer cells and autoimmunity. Arthritis Res Ther (2003) 1.14
Expression of m157, a murine cytomegalovirus-encoded putative major histocompatibility class I (MHC-I)-like protein, is independent of viral regulation of host MHC-I. J Virol (2006) 1.13
Ly49h is necessary for genetic resistance to murine cytomegalovirus. Immunogenetics (2008) 1.12
Memory-like responses of natural killer cells. Immunol Rev (2010) 1.11
Streptolysin O clearance through sequestration into blebs that bud passively from the plasma membrane. J Cell Sci (2011) 1.11
Natural killer cells in human autoimmune disorders. Arthritis Res Ther (2013) 1.10
Rat NKp46 activates natural killer cell cytotoxicity and is associated with FcepsilonRIgamma and CD3zeta. J Leukoc Biol (2004) 1.10
Mechanisms involved in synergistic anticancer immunity of anti-4-1BB and anti-CD4 therapy. Cancer Res (2007) 1.08
Stability of murine cytomegalovirus genome after in vitro and in vivo passage. J Virol (2009) 1.08
Interferon-γ mediates chemokine-dependent recruitment of natural killer cells during viral infection. Proc Natl Acad Sci U S A (2012) 1.08
IL-18 acts synergistically with IL-15 in stimulating natural killer cell proliferation. Cytokine (2006) 1.07
Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells. Nat Immunol (2012) 1.05
A ligand for the murine NK activation receptor Ly-49D: activation of tolerized NK cells from beta 2-microglobulin-deficient mice. J Immunol (2002) 1.04
Arrested natural killer cell development associated with transgene insertion into the Atf2 locus. Blood (2005) 0.99
Viral MHC class I inhibition evades CD8+ T-cell effector responses in vivo but not CD8+ T-cell priming. Proc Natl Acad Sci U S A (2012) 0.99
Ly49H+ NK cells migrate to and protect splenic white pulp stroma from murine cytomegalovirus infection. J Immunol (2008) 0.96
Critical negative regulation of type 1 T cell immunity and immunopathology by signaling adaptor DAP12 during intracellular infection. J Immunol (2007) 0.96
NK cells use NKG2D to recognize a mouse renal cancer (Renca), yet require intercellular adhesion molecule-1 expression on the tumor cells for optimal perforin-dependent effector function. J Immunol (2006) 0.95
DAP10 associates with Ly49 receptors but contributes minimally to their expression and function in vivo. Eur J Immunol (2009) 0.93
The gp49B1 inhibitory receptor regulates the IFN-gamma responses of T cells and NK cells. J Immunol (2003) 0.92
NKG2D-independent suppression of T cell proliferation by H60 and MICA. Proc Natl Acad Sci U S A (2005) 0.92
Murine cytomegalovirus protein pM79 is a key regulator for viral late transcription. J Virol (2013) 0.92
Strain-specific variation in murine natural killer gene complex contributes to differences in immunosurveillance for urethane-induced lung cancer. Cancer Res (2012) 0.92
Natural killer cell licensing in mice with inducible expression of MHC class I. Proc Natl Acad Sci U S A (2013) 0.90
Rapid emergence of escape mutants following infection with murine cytomegalovirus in immunodeficient mice. Clin Immunol (2005) 0.89
Ly49-dependent NK cell licensing and effector inhibition involve the same interaction site on MHC ligands. J Immunol (2011) 0.88
Development of thymic NK cells from double negative 1 thymocyte precursors. Blood (2011) 0.87
Natural killer cell-mediated lysis of dorsal root ganglia neurons via RAE1/NKG2D interactions. Eur J Immunol (2003) 0.86
Recognition of infected cells by natural killer cells. Curr Opin Immunol (2004) 0.86
Thymic stromal lymphopoietin blocks early stages of breast carcinogenesis. J Clin Invest (2016) 0.86
Contrasting roles of the IL-1 and IL-18 receptors in MyD88-dependent contact hypersensitivity. J Invest Dermatol (2010) 0.85
Evidence for high bi-allelic expression of activating Ly49 receptors. Nucleic Acids Res (2009) 0.84
Flow cytometry analysis using the Becton Dickinson FACS Calibur. Curr Protoc Immunol (2002) 0.84
Molecular genetic characterization of the distal NKC recombination hotspot and putative murine CMV resistance control locus. Immunogenetics (2003) 0.83
Reduction of streptolysin O (SLO) pore-forming activity enhances inflammasome activation. Toxins (Basel) (2013) 0.83
Distal-less homeobox transcription factors regulate development and maturation of natural killer cells. Proc Natl Acad Sci U S A (2008) 0.83
Cowpox virus employs a two-pronged strategy to outflank MHCI antigen presentation. Mol Immunol (2013) 0.82
Inositol tetrakisphosphate limits NK cell effector functions by controlling PI3K signaling. Blood (2012) 0.82
Assessing licensing of NK cells. Methods Mol Biol (2010) 0.81
Corrigendum: Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature (2015) 0.81
Chronic lymphocytosis of functionally immature natural killer cells. J Allergy Clin Immunol (2007) 0.81
Primary naive and interleukin-2-activated natural killer cells do not support efficient ectromelia virus replication. J Gen Virol (2008) 0.81
Isolation of murine natural killer cells. Curr Protoc Immunol (2014) 0.80
Murine trophoblast cells induce NK cell interferon-gamma production through KLRK1. Biol Reprod (2010) 0.78
Chronic allergic contact dermatitis promotes skin cancer. J Clin Invest (2014) 0.77
Contact hypersensitivity: not just T cells! Nat Immunol (2006) 0.77
Regulation of the NK cell alloreactivity to bone marrow cells by the combination of the host NK gene complex and MHC haplotypes. J Immunol (2008) 0.77
Innate immunity to pathogens. Curr Opin Immunol (2008) 0.75
Immunology: catch us if you can. Nature (2002) 0.75
Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression. Immunity (2017) 0.75